ARTICLE IEscrow Agreement • August 28th, 2002 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
WARRANTWarrant Agreement • June 17th, 2004 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
COMMON STOCK PURCHASE WARRANT Microbot Medical Inc.Common Stock Purchase Warrant • January 25th, 2019 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 24th, 2023 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of May 23, 2023, between Microbot Medical Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
WARRANTWarrant Agreement • December 7th, 2001 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
AGREEMENT AND PLAN OF MERGER BY AND AMONG CytoTherapeutics, Inc. and CTI Acquisition, Corp. and StemCells, Inc. Dated as of August 13, 1997 ---------------------------------------------------------------------...Merger Agreement • November 14th, 1997 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances) • California
EXHIBIT 10.55 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT, dated as of June 21, 2001, (this "Agreement") is made by and between STEMCELLS, INC., a Delaware corporation (the "Company"), and the entity named on the signature page...Registration Rights Agreement • June 29th, 2001 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
Exhibit 10.1 StemCells, Inc. 3155 Porter Drive Palo Alto, CA 94304 Attention: Chief Executive Officer Ladies and Gentlemen: The undersigned, ________________________________ (the "Investor"), hereby confirms its agreement with you as follows: 1. This...Purchase Agreement • October 26th, 2004 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
andRights Agreement • August 3rd, 1998 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 4.15 NEITHER THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM...Common Stock Purchase Warrant • June 29th, 2001 • Stemcells Inc • Biological products, (no disgnostic substances)
CYTOTHERAPEUTICS, INC. CONSULTING AGREEMENT -- WEISSMAN This Agreement, dated as of September 25, 1997, is between Irving Weissman, M.D., an individual with an address at 4147 Jefferson, Redwood City, California 94062 (the "Consultant") and...Consulting Agreement • November 14th, 1997 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances) • Rhode Island
BETWEENRegistration Rights Agreement • December 5th, 2000 • Stemcells Inc • Biological products, (no disgnostic substances) • Delaware
ESCROW AGREEMENTEscrow Agreement • May 25th, 2001 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 29th, 2023 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of June 26, 2023, between Microbot Medical Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
ARTICLE 1Common Stock Purchase Agreement • May 25th, 2001 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
Common Stock ($0.01 Par Value)Agency Agreement • October 26th, 2004 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
As of July 1, 1999 John Schwartz 110 Atherton Avenue Atherton, California 94027 Dear John: This letter will confirm our agreement with respect to the amendment, with effect from July 1, 1999, of your Letter Agreement with CytoTherapeutics, Inc. (the...Letter Agreement • April 17th, 2000 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances)
EXHIBIT 99.2 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "AGREEMENT"), dated as of May __, 2003, by and among StemCells, Inc., a Delaware corporation, with headquarters located at 3155 Porter Drive, Palo Alto, California 94304...Registration Rights Agreement • May 13th, 2003 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.81Consulting Services Agreement • March 31st, 1999 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances) • Delaware
WARRANT STEMCELLS, INC.Warrant Agreement • July 15th, 2014 • Stemcells Inc • Biological products, (no disgnostic substances)
THIS WARRANT (the “Warrant”) certifies that, for value received, or its permitted assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the 6 month anniversary of the Issue Date (the “Initial Exercise Date”) and prior to the close of business on the 13 month anniversary of the Issue Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from StemCells, Inc., a Delaware corporation (the “Company”), up to shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
AMONGSecurities Purchase Agreement • December 5th, 2000 • Stemcells Inc • Biological products, (no disgnostic substances) • California
CYTOTHERAPEUTICS, INC. Two Richmond Square Providence, RI 02906 401-272-3310 September 25, 1997Employment Agreement • March 31st, 1998 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances) • Rhode Island
PRE-FUNDED COMMON STOCK PURCHASE WARRANT Microbot Medical Inc.Pre-Funded Common Stock Purchase Warrant • October 25th, 2022 • Microbot Medical Inc. • Biological products, (no disgnostic substances)
THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Microbot Medical Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EXHIBIT 10.49 SUBSCRIPTION AGREEMENT DATED AS OF JULY 31, 2000 BY AND BETWEEN STEMCELLS, INC.Subscription Agreement • September 8th, 2000 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
STEMCELLS, INC.Stock Purchase Warrant • May 25th, 2001 • Stemcells Inc • Biological products, (no disgnostic substances) • Delaware
RECITALSEmployment Agreement • December 5th, 2000 • Stemcells Inc • Biological products, (no disgnostic substances) • Rhode Island
EXHIBIT 10.56 SUBSCRIPTION AGREEMENT DATED AS OF JUNE 21, 2001 BY AND BETWEEN STEMCELLS, INC.Subscription Agreement • June 29th, 2001 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.48 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT, dated as of July 31, 2000 (this "Agreement"), is made by and between STEMCELLS, INC., a Delaware corporation (the "Company"), and the entity named on the signature page...Registration Rights Agreement • September 8th, 2000 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
6% CONVERTIBLE DEBENTURE DUE NOVEMBER 28, 2019Convertible Security Agreement • November 29th, 2016 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
THIS 6% CONVERTIBLE DEBENTURE is one or more of a series of duly authorized and validly issued 6% Convertible Debentures of Microbot Medical Inc. (formerly known as Stemcells, Inc.), a Delaware corporation (the “Company”), having its principal place of business at 5 Hamada Street, Yokneam 2069204 Israel, designated as its 6% Convertible Debenture due November 28, 2019 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
RECITALSSecurities Purchase Agreement • June 17th, 2004 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
AT THE MARKET OFFERING AGREEMENTAt the Market Offering Agreement • June 10th, 2021 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
Microbot Medical Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows:
35,715,000 SHARES OF COMMON STOCK AND 26,786,250 WARRANTS OF STEMCELLS, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • April 27th, 2015 • Stemcells Inc • Biological products, (no disgnostic substances) • New York
The undersigned, StemCells, Inc., a company incorporated under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of StemCells, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for whom Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
CYTOTHERAPEUTICS, INC. Two Richmond Square Providence, RI 02906 401-272-3310 September 25, 1997Employment Agreement • November 14th, 1997 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances) • Rhode Island
FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 30th, 2019 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 27, 2019, between Microbot Medical Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
EXHIBIT 10.58 LEASE AGREEMENT DATED AS OF NOVEMBER 21, 1997 BY AND BETWEENLease Agreement • March 31st, 1998 • Cytotherapeutics Inc/De • Biological products, (no disgnostic substances) • Maryland
